Product Images Klor-con

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 2 images provide visual information about the product associated with Klor-con NDC 0245-5316 by Upsher-smith Laboratories, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PRINCIPAL DISPLAY PANEL - 600 mg Tablet Bottle Label - klor con 01

PRINCIPAL DISPLAY PANEL - 600 mg Tablet Bottle Label - klor con 01

Klor-Con 8 is a medication that contains 600 mg of Potassium Chloride per extended-release tablet. It is used to treat or prevent certain types of low potassium levels in the blood. Dosage and usage instructions can be found in the package insert. Dosage must be adjusted according to individual needs. The tablets should be stored at room temperature, away from children, in a tightly closed container. Upsher-Smith Laboratories, LLC manufactures Klor-Con 8.*

PRINCIPAL DISPLAY PANEL - 750 mg Tablet Bottle Label - klor con 02

PRINCIPAL DISPLAY PANEL - 750 mg Tablet Bottle Label - klor con 02

Each extended-release tablet contains: Potassium chloride, USP 750 mg (equivalent to potassium 10 mEq) with Klor-con 10 as the usual dosage. Dosage must be adjusted to the individual needs for each patient. It must be stored in a tight container with a child-resistant closure at a temperature between 20°C to 25°C (68°F to 77°F) and excursions permitted to 15° to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. This medication is manufactured by Upsher-Smith Laboratories LLC and is available only under Rx. Kior-Con is a registered trademark of Upsher-Smith Laboratories LLC.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.